Abstract | OBJECTIVE: METHODS: Eighteen pregnant women received prednisone (10 mg/day) and plasmapheresis at 7.08+/-0.6 weeks of gestation, for 3 sessions per week, until lupus anticoagulant activity suppressed and IgG anticardiolipin lowered. Serial pulsatility indexes (PI) of umbilical and uterine arteries were performed. RESULTS: CONCLUSION:
|
Authors | D O El-Haieg, M F Zanati, F M El-Foual |
Journal | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
(Int J Gynaecol Obstet)
Vol. 99
Issue 3
Pg. 236-41
(Dec 2007)
ISSN: 0020-7292 [Print] United States |
PMID | 17897649
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents
- Prednisone
|
Topics |
- Abortion, Habitual
(therapy)
- Adult
- Anti-Inflammatory Agents
(therapeutic use)
- Antiphospholipid Syndrome
(therapy)
- Female
- Humans
- Live Birth
- Pilot Projects
- Plasmapheresis
- Prednisone
(therapeutic use)
- Pregnancy
- Pregnancy Complications, Hematologic
(therapy)
- Pulsatile Flow
|